An in vivo transient cerebral I/R study demonstrated that andrographolide derivative CX-10 induced Nrf2 expression, down-regulated the expression of inducible nitric oxide synthase (iNOS), thus exhibited neuroprotective effects, including reduced cerebral infarction and improved neurological impairment [66]. The gene discussed is NOS2; the disease is cerebral infarction.